however, several in vitro cell culture and in vivo animal model studies have investigated the direct treatment of airway cells with NAC
In animal models of colitis, TUDCA reduced intestinal inflammation, improved barrier function, and protected gut cells from stress-related injury.26 A recent study in animals and intestinal cells found that TUDCA improved gut barrier integrity and shifted gut bacteria, changes that could reduce inflammation.27 In humans, an open-label pilot trial of 13 patients with active UC found that 6 weeks of TUDCA was safe and associated with improvements in ER stress markers, mucosal healing, and clinical disease activity.37 However, because this study had no placebo group and was very small, larger randomized trials are needed to confirm the benefit
BPC-157 and TB-500 on the other hand still lack randomized controlled trials in humans
One-way analysis of variance was used to determine the significance of differences
Supplied as a lyophilized powder, independently tested, and supported by a lot-specific Certificate of Analysis
Liver transplantation provides a more permanent benefit ( 220 )